Table 3 Clinical manifestations and immunologic evaluation of subjects with cefaclor immediate HS
Cefaclor immediate HS n = 459 (%) | |
|---|---|
Causality | |
Certain | 195 (42.5) |
Probable | 111 (24.2) |
Possible | 153 (33.3) |
Clinical manifestations | |
Urticaria/skin rash | 339 (73.9) |
Angioedema | 146 (31.8) |
Dyspnea/hypoxemia | 208 (45.3) |
Hypotension | 74 (15.9) |
Altered mental status | 29 (6.3) |
Anaphylaxis | 281 (61.2) |
Serum specific IgE to cefaclor (+) | 181/333 (54.3) |
Skin test to cefaclor (+) | 2/22 (9.1) |
Provocation test to cefaclor (+) | 22/22 (100) |